Sunitinib
An indole and pyrrole derivative that inhibits VEGFR-2 and PDGFR BETA RECEPTOR TYROSINE KINASES. It is used as an antineoplastic agent for the treatment of GASTROINTESTINAL STROMAL TUMORS, and for treatment of advanced or metastatic RENAL CELL CARCINOMA.
Year introduced: 2019 (2003)
PubMed search builder options
Subheadings:
Tree Number(s): D03.383.129.578.823, D03.633.100.473.877
MeSH Unique ID: D000077210
Registry Number: V99T50803M
Entry Terms:
- 5-(5-Fluoro-2-oxo-1,2-dihydroindolylidenemethyl)-2,4-dimethyl-1H-pyrrole-3-carboxylic acid (2-diethylaminoethyl)amide
- Sunitinib Malate
- Sutent
- SU 11248
- SU011248
- SU 011248
- SU-011248
- SU11248
- SU-11248
Pharmacologic Action: